Kevin Kuo
@CaptainAV
Followers
499
Following
1K
Media
491
Statuses
2K
blood doctor finding new treatments for #Thalassemia #SickleCell #PKdeficiency #HS #HE/#HPP #CDA #G6PD, @UofT_DoM @ihpmeuoft also @MSF Tweets are my own
Joined July 2011
TEMPI syndrome: Telangiectasias, Erythrocytosis with elevated erythropoietin levels, Monoclonal gammopathy, Perinephric-fluid collections, Intrapulmonary shunting. https://t.co/Pj7oDj5zaZ
0
1
2
Dr. Stefano Rivella presented a new alpha globin gene addition vector that can rescue alpha thalassemia knock out mice @CanHaem annual meeting in @Vancouver
1
0
0
The science fiction movie Day After Tomorrow does not seem so far fetched anymore The shutdown of ocean currents could freeze Europe (from @TheEconomist)
economist.com
When climate change poses a strategic threat, it needs a strategic response
0
0
0
Dr. Brid Ryan presented on a small activating RNA induction of HBG via liposome delivery for in vivo treatment of SCD. Looks like one needs monthly injection to sustain HbF >20%.
1
0
0
Dr. Lucia de Franceschi gave a wonderful talk on the mathematical modelling of red blood cell and its components #EHA2025
1
3
6
Congratulations to Dr. Rachael Grace on the successful completion of the trial on MITAPIVAT IN PEDIATRIC PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED: RESULTS FROM THE PHASE 3 RANDOMIZED GLOBAL PLACEBO-CONTROLLED ACTIVATE-KIDS TRIAL #EHA2025
1
2
7
Congratulations to Thomas Doeven and the SATISFY team for a very SATISFYing result! SATISFY: MITAPIVAT IN ADULTS WITH ERYTHROCYTE MEMBRANOPATHIES AND CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II: A EUROBLOODNET, MULTICENTER, SINGLE-ARM, PHASE 2 STUDY. #EHA2025
0
2
7
It is not everyday that a new enzymopathy is found! Ruiter T, et al. NMNAT3 DEFICIENCY: A NOVEL RED BLOOD CELL ENZYMOPATHY. #EHA2025
1
4
10